A Combination of Systemic and Intracranial Anti-CD25 Immunotherapy Elicits a Long-Time Survival in Murine Model of Glioma
Figure 5
Phenotype of CD8+ CTL induced by anti-CD25 combined immunotherapy. (a) Dot plots of FACS analysis of triple staining for expression of CD8, CD44, and CD62L, after gating the CD8+ T cell population in comparison with untreated glioma-bearing mice. (b) Cytokine intracellular staining of IL-4 and INF- (c) versus CD8. The mean fluorescence intensity of each marker is given in each dot plot. Values represent the mean fluorescence intensity of three independent experiments SD.
